Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check7 days agoChange DetectedA new revision tag v3.5.4 was added and the previous v3.5.3 tag was removed, signaling an update to the page version.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s displayed release/version identifier was updated from “v3.5.2” to “v3.5.3,” reflecting a change in the ClinicalTrials.gov site build rather than the underlying study details.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other content changes are indicated.SummaryDifference0.1%

- Check64 days agoChange DetectedPage revision tag updated to v3.5.0, replacing the previous v3.4.3. This appears to be a minor maintenance update unrelated to study data or usability.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's revision label has been updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.